Background-Obstructive sleep apnea (OSA) has been increasingly linked to cardiovascular and cerebrovascular disease.Inflammatory processes associated with OSA may contribute to cardiovascular morbidity in these patients. We tested the hypothesis that OSA patients have increased plasma C-reactive protein (CRP). Methods and Results-We studied 22 patients (18 males and 4 females) with newly diagnosed OSA, who were free of other diseases, had never been treated for OSA, and were taking no medications. We compared CRP measurements in these patients to measurements obtained in 20 control subjects (15 males and 5 females) who were matched for age and body mass index, and in whom occult OSA was excluded. Plasma CRP levels were significantly higher in patients with OSA than in controls (median Epidemiological studies show that an elevated CRP level in the high-normal (0.2 to 1.5 mg/dL) range in apparently healthy men and women is a strong predictor of cardiovascular risk. 7,8 In patients with acute coronary artery disease, stable angina pectoris, and a history of myocardial infarction, higher CRP is also associated with future cardiovascular events. 9 10 OSA results in repetitive and severe nocturnal hypoxemia and sleep disturbances. 11 The hypoxemia of high altitude results in increases in interleukin-6 (IL-6) 12 and CRP 12,13 in normal humans. Sleep deprivation also induces an increase in cytokines. 4,14 We tested the hypothesis that OSA patients have increased plasma CRP.
MethodsWe compared subjects with moderate to severe OSA (apnea hypopnea index [AHI] Ն20) to those without OSA (AHI Յ5). We studied 22 patients (18 males and 4 females) with newly diagnosed OSA, who were free of other diseases, had never been treated for OSA, and were taking no medications. We compared CRP measurements in these patients to measurements obtained from 20 control subjects (15 males and 5 females) who were matched for age and body mass index (BMI), and in whom occult OSA was excluded. The control group was free of any acute or chronic cardiovascular, inflammatory, or sleep disorders, and no control subjects were taking medications at the time of the sleep study. The presence and severity of sleep apnea were determined by standard overnight polysomnography, including electroencephalography, electrooculography, electromyography, oximetry, thermistor measurements of airflow, and measurements of rib cage and abdominal movements when breathing. The sleep studies followed a split-night protocol. The first half of the study intended to diagnose OSA, with a therapeutic trial of continuous positive airway pressure during the second half of the night. An apnea was defined as complete cessation of airflow for at least 10 seconds. Hypopnea was defined as a reduction of respiratory signals for at least 10 seconds associated with oxygen desaturation of Ն4%. The AHI was calculated as the total number of respiratory events per hour of sleep.Baseline demographic data, heart rate, blood pressure (SpaceLabs blood pressure monitor 90207), and venous blood ...